Ideally, our nation's pharmaceutical supply chain should provide medicines and medical supplies of the highest quality, in the right quantity, to the right customer at the right place. Supplies should arrive at the right time, and at a fair cost that is aligned with broader public health improvement goals for individuals and communities. Panelists will explore the dynamics of the pharmaceutical supply chain in the US from the public health perspective, drawing on lessons learned from the COVID-19 pandemic. Subject matter experts will discuss upstream and downstream aspects of today's supply chain and envision the future of the pharmaceutical supply chain to realize optimal efficiency, delivery, and resilience across the US healthcare ecosystem while advancing public health.
Washington Correspondent, STAT
Executive Director, Healthcare Ready
President and CEO, Healthcare Distribution Alliance
Director, Duke-Margolis Center for Health Policy, Duke University
President and CEO, National Minority Quality Forum